Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies.

Simpson EL, Guttman-Yassky E, Pawlikowski J, Ghorayeb EG, Ota T, Lebwohl MG

Open source

DOI
10.1007/s00403-024-03319-z
Published
2024 Aug 30
Container
Archives of dermatological research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00403-024-03319-z,
  title = {Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies.},
  author = {Simpson EL and Guttman-Yassky E and Pawlikowski J and Ghorayeb EG and Ota T and Lebwohl MG},
  year = {2024},
  journal = {Archives of dermatological research},
  doi = {10.1007/s00403-024-03319-z},
  url = {https://doi.org/10.1007/s00403-024-03319-z}
}

RIS

TY  - JOUR
TI  - Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies.
AU  - Simpson EL
AU  - Guttman-Yassky E
AU  - Pawlikowski J
AU  - Ghorayeb EG
AU  - Ota T
AU  - Lebwohl MG
PY  - 2024
JO  - Archives of dermatological research
DO  - 10.1007/s00403-024-03319-z
UR  - https://doi.org/10.1007/s00403-024-03319-z
ER  - 

APA

EL, S., E, G., J, P., EG, G., T, O., & MG, L. (2024). Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies.. Archives of dermatological research. https://doi.org/10.1007/s00403-024-03319-z

Source records